Lazard：2026年医疗服务行业领导者研究报告（英文版）

Throughout 2025 and into early 2026, healthcare services companies navigated a volatile macroeconomic,geopolitical and policy landscape. Trade tensions rose precipitously following the implementation ofsweeping universal tariffs in 2025, which drove US import duties to levels not seen since the 1930s. Thisaggressive trade posture spiked market volatility and heightened concerns regarding supply chain inflationand cross-border pharmaceutical activities. A February 2026 Supreme Court ruling str